Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry E Storer

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 1, 2019
Allogeneic Hematopoietic Cell Transplantation in the Outpatient SettingNoa Granot, Barry E Storer, Jason P Cooper, et al.
Leukemia & Lymphoma|January 23, 2019
Second allogeneic hematopoietic cell transplantation for relapse after first allograftsBoglarka Gyurkocza, Rainer Storb, Thomas R Chauncey, et al.
Haematologica|September 24, 2013
Response endpoints and failure-free survival after initial treatment for acute graft-versus-host diseaseYoshihiro Inamoto, Paul J Martin, Barry E Storer, et al.
The Oncologist|May 7, 2014
Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimensNandita Khera, Amy Emmert, Barry E Storer, et al.
Blood|July 19, 2003
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplantsTodd D Freudenberger, David K Madtes, J Randall Curtis, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2015
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipientsJeannine S McCune, Donald E Mager, Meagan J Bemer, et al.
Blood|May 20, 2015
Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatmentGeorge B McDonald, Laura Tabellini, Barry E Storer, et al.
Blood|October 6, 2007
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemiaMohamed L Sorror, Barry E Storer, David G Maloney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantationMarco Mielcarek, Barry E Storer, Mary E D Flowers, et al.
Blood Advances|July 21, 2020
Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantationPaul J Martin, David M Levine, Barry E Storer, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 1, 2019
Allogeneic Hematopoietic Cell Transplantation in the Outpatient SettingNoa Granot, Barry E Storer, Jason P Cooper, et al.
Leukemia & Lymphoma|January 23, 2019
Second allogeneic hematopoietic cell transplantation for relapse after first allograftsBoglarka Gyurkocza, Rainer Storb, Thomas R Chauncey, et al.
Haematologica|September 24, 2013
Response endpoints and failure-free survival after initial treatment for acute graft-versus-host diseaseYoshihiro Inamoto, Paul J Martin, Barry E Storer, et al.
The Oncologist|May 7, 2014
Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimensNandita Khera, Amy Emmert, Barry E Storer, et al.
Blood|July 19, 2003
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplantsTodd D Freudenberger, David K Madtes, J Randall Curtis, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2015
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipientsJeannine S McCune, Donald E Mager, Meagan J Bemer, et al.
Blood|May 20, 2015
Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatmentGeorge B McDonald, Laura Tabellini, Barry E Storer, et al.
Blood|October 6, 2007
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemiaMohamed L Sorror, Barry E Storer, David G Maloney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantationMarco Mielcarek, Barry E Storer, Mary E D Flowers, et al.
Blood Advances|July 21, 2020
Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantationPaul J Martin, David M Levine, Barry E Storer, et al.
Pageof 18